Business Wire

Play Your Way to the Malta Poker Festival $500k GTD with Intertops Poker

26.7.2019 17:17:00 EEST | Business Wire | Press release

Share

How do you fancy winning a place at the Malta Poker Festival €500,000 GTD? Intertops Poker is giving you a chance to win a seat at the table via a number of satellite tournaments starting on 29th July.

The Malta Poker Festival €500,000 GTD takes place from 30th October – 4th November 2019 and as one of the Intertops Poker satellite winners you will receive a truly VIP stay during the tournament and that all important chance to take home the top prize.

The satellite winner package is worth €2,500 and includes:

  • Buy-in to the MPF main event, Day1C, November 1st
  • 5-night stay for two in a luxury room at the Hilton 5* Malta Resort
  • Tickets for the exclusive MPF VIP Player party
  • $500 to help with travel expenses
  • Dinner with the Intertops Poker Team
  • Intertops Poker Gear

Satellite tournaments will take place on the following days and at the following times between 29th July and 4th August 2019.

Malta Poker Festival €500,000 GTD Step 1 $2+$0.20
Daily, starting July 29th to August 3rd
starting times: 6:10pm / 12:10am / 6:10am / 12:10pm (all times in EDT)
(12:10pm / 6:10pm / 12:10am / 6:10am - all times in CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Step 2 guaranteed! »

Malta Poker Festival €500,000 GTD Step 2 $10+$1
Daily, starting July 29th to August 4th
starting times: 7:10pm / 1:10am / 7:10am / 1:10pm (all times in EDT)
(1:10pm / 7:10pm / 1:10am / 7:10am - all times in CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »

Malta Poker Festival €500,000 GTD - 'ULTIMATE' - FREEROLL
Sunday, August 4th at 2am EDT (8am CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »

Malta Poker Festival €500,000 GTD - Last Chance I - $8+$0.80
Sunday, August 4th at 5am EDT (11am CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »

Malta Poker Festival €500,000 GTD - Last Chance II - $8+$0.80
Sunday, August 4th at 8am EDT (2pm CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »

Malta Poker Festival €500,000 GTD Satellite Final $100+$10
Sunday, August 4th at 1:10pm EDT (7:10pm CEST)
« 1x Malta Poker Festival €500,000 GTD package guaranteed! »

In addition, if you would like to keep up to speed with all the action from the European Poker Championship from Casino Velden in Austria you can follow our daily updates and coverage here.

ENDS

Editor’s notes:
About Intertops Poker:
Intertops Poker

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

GameOn Marketing
Sarah Blackburn | Director | GameOn
0034628499459

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SMBC and Toshiba Jointly Develop New Equity Indices Using Advanced Quantum-Driven Technologies28.5.2026 04:00:00 EEST | Press release

Sumitomo Mitsui Banking Corporation (“SMBC”) and Toshiba Corporation (“Toshiba”) today announced the joint development of the SMBC/TOSHIBA Quantum Driven Diversified Japan Equity Index and the SMBC/TOSHIBA Quantum Driven Diversified U.S. Equity Index, new equity indices realized with advanced quantum-driven technologies. Collectively, the indices are referred to as “SMBC/TOSHIBA Quantum Diversified” (the “Indices”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519448161/en/ Toshiba’s Simulated Bifurcation Machine 1. Background and Objectives Equity investment is central to asset management, but it also carries the ever-present risk of abrupt and substantial market fluctuations driven by geopolitical developments, changes in economic policy, and other external factors. In uncertain markets, investors are constantly seeking innovations in risk diversification that can protect their assets from unexpected market shocks. SM

BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 202628.5.2026 00:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be presented in an oral presentation (Rapid Oral Abstract: 4010) at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2026, in Chicago.The HERIZON-GEA-01 clinical trial evaluated ZIIHERA® (zanidatamab) plus chemotherapy, with and without TEVIMBRA® (tislelizumab), compared with the control arm of trastuzumab plus chemotherapy as first-line treatment for advanced/metastatic HER2+ gastroesophageal adenocarcinoma (GEA). Dr. Sun Young Rha, Professor of Medical Oncology at the Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea, senior author of the NEJM manuscript and first author of the ASCO abstract, said: “Results from the HERIZON-GEA-01 published in The New England Journal of Medicine and presented in an oral presentation at ASCO provide ne

Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards27.5.2026 18:22:00 EEST | Press release

The Stallergenes Greer Foundation, dedicated to advancing allergy research, fostering innovation and addressing environmental factors which impact allergies, is delighted to announce the recipients of the 2025 edition of its prestigious Science Awards for Allergy. Building on the success of the previous edition, this year’s awards recognise outstanding contributions to allergy research and patient engagement and allocate a total of €100,000 to support these initiatives. Four researchers have been selected by the Board as award recipients, each receiving €25,000 across two categories: Innovation In Treatment Awards Assoc. Professor Alexander Eggel, PhD, Department for Biomedical Research, University of Bern, and Department of Rheumatology and Immunology, University Hospital Bern, Switzerland, recognised for his research: “Improving diagnostic and therapeutic options for allergic patients”; Dr Janice A. Layhadi, PhD, Research Associate, National Heart and Lung Institute, Imperial College

Capchase Secures $200M+, as Demand for Vendor Financing in Enterprise Tech Deals Accelerates27.5.2026 17:00:00 EEST | Press release

Capchase, the leading vendor financing platform for enterprise tech, today announced $200M+ in incremental funding to scale its embedded financing infrastructure globally and deploy more AI-enabled features. The funding, a mix of debt warehouse facilities and equity backed by institutional investors, reflects market validation that vendor financing has become essential infrastructure for enterprise technology companies to sell hardware and software products. As global B2B buyers face tighter budgets and greater scrutiny over large, up-front purchases, financing demand is growing. The Market Shift: Financing as a Growth Lever for B2B Tech Companies The $1.3 trillion vendor financing market has been traditionally dominated by banks and other lenders that utilize multi-thread email chains to manual doc review for underwriting. Capchase replaces those bottlenecks with financing tech embedded directly into sales tools such as Salesforce, enabling 97% of lending applications to be vetted and

ClickHouse Tops $250M ARR and 4,000 Customers, Launches Claude-Powered Agents at Open House 202627.5.2026 16:00:00 EEST | Press release

ClickHouse today opened Open House 2026, its second annual user conference, with a set of announcements that mark one of the company's most active quarters since founding. ClickHouse’s serverless cloud offering has crossed over $250 million in annual run-rate revenue — more than triple a year ago — and added more than 1,000 net new customers since January, bringing its total to 4,000. To meet the demands of AI-era workloads, the company also launched ClickHouse Agents, a fully managed agentic analytics service powered by Anthropic's Claude; published CostBench, an open benchmark comparing the major cloud data warehouses on cost-performance; and introduced House Mates, its first formal partner program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527813115/en/ ClickHouse Co-Founders (left to right): Yury Izrailevsky, Aaron Katz, Alexey Milovidov Growth When ClickHouse closed its $400 million Series D in January 2026, it

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye